We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 27, 2020

Response Rate and Local Recurrence After Concurrent Immune Checkpoint Therapy and Radiotherapy for NSCLC and Melanoma Brain Metastases

Cancer

 

Additional Info

Cancer
Response Rate and Local Recurrence After Concurrent Immune Checkpoint Therapy and Radiotherapy for Non-Small Cell Lung Cancer and Melanoma Brain Metastases
Cancer 2020 Sep 14;[EPub Ahead of Print], JM Qian, AM Martin, K Martin, L Hammoudeh, PJ Catalano, FS Hodi, DN Cagney, DA Haas-Kogan, JD Schoenfeld, AA Aizer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading